C. Richter (Rick), PhD, is director of research and development (R&D) and serves on the leadership team at MVI. In addition, he leads the transmission-blocking vaccine program, a priority area of product development for MVI.
Rick was formerly Vice President of Vaccine Design for IAVI’s AIDS Vaccine Design. He led IAVI's global efforts to design and prioritize novel AIDS vaccine strategies. Rick is an accomplished scientist whose career spans government, academia, and industry. As former Senior Vice President of Research at GenVec, Inc., he led the company's efforts in the identification, selection, and advancement of products for cancer, ocular and infectious disease applications. Rick has been the author and recipient of many peer-reviewed grants and is listed as an inventor on 12 issued patents. He received his Ph.D. in biochemistry from Johns Hopkins University and his BS from the University of St. Andrews.